Genes (Feb 2022)

Epigenetic and Epitranscriptomic Control in Prostate Cancer

  • Judith López,
  • Ana M. Añazco-Guenkova,
  • Óscar Monteagudo-García,
  • Sandra Blanco

DOI
https://doi.org/10.3390/genes13020378
Journal volume & issue
Vol. 13, no. 2
p. 378

Abstract

Read online

The initiation of prostate cancer has been long associated with DNA copy-number alterations, the loss of specific chromosomal regions and gene fusions, and driver mutations, especially those of the Androgen Receptor. Non-mutational events, particularly DNA and RNA epigenetic dysregulation, are emerging as key players in tumorigenesis. In this review we summarize the molecular changes linked to epigenetic and epitranscriptomic dysregulation in prostate cancer and the role that alterations to DNA and RNA modifications play in the initiation and progression of prostate cancer.

Keywords